Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2019-06-24 Major Shareholding Noti…
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
190624 PELION zawiadomienie
Major Shareholding Notification Classification · 98% confidence The document text is a formal notification in Polish, explicitly referencing 'Informacje przekazywane do Komisji Nadzoru Finansowego' (Information provided to the Financial Supervision Authority) based on Polish public offering laws (art. 69 ustawy z dnia 29 lipca 2005r.). The content details changes in shareholding percentage (from 58.7% to 61.1%) following a capital increase ('rejestracja podwyższenia kapitału'). This structure—reporting changes in significant share ownership thresholds to a regulatory body—directly corresponds to the definition of Major Shareholding Notification (MRQ). It is not an Annual Report (10-K), Earnings Release (ER), or a general Regulatory Filing (RNS), as it pertains to a specific insider/major shareholder disclosure requirement.
2019-06-24 Polish
Ujawnienie stanu posiadania - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document is very short (435 characters) and explicitly states that the company received a notification ('zawiadomienie') under Article 69 of the Public Offering Act and that this notification is attached as an annex to the current report. This structure—announcing receipt of information and attaching it—is characteristic of a regulatory disclosure. Since the content is about a notification regarding share ownership change (implied by referencing Article 69, which deals with major shareholdings), the most specific category would be Major Shareholding Notification (MRQ). However, given the very short length and the nature of simply reporting the receipt of an external filing, it could also be classified as a general Regulatory Filing (RNS) or a Report Publication Announcement (RPA) if it were announcing the publication of its own report. Since it is reporting the receipt of a notification under Polish law (Art. 70 pkt. 1), and the core subject is a change in significant shareholding (Art. 69), MRQ is the most appropriate specific classification, even if the actual details are in the attachment. If MRQ were not available, RNS would be the fallback. Given the context of Polish regulatory filings, MRQ is the best fit for reporting on Article 69 notifications.
2019-06-24 Polish
Spłata istotnych pożyczek - realizacja jednego z celów emisji akcji serii E - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by the Management Board (Zarząd) of PHARMENA S.A. (Emitent) regarding the repayment of three loans using funds obtained from a Series E share issuance. It details the repayment amounts, recipients (including a leading shareholder and senior management), and links this action back to the goals stated in the share issuance prospectus. This type of disclosure, concerning the use of proceeds from financing activities and related party transactions, falls under corporate financing updates or regulatory disclosures related to capital structure changes. Since the core event is the repayment of debt financed by equity issuance, it strongly relates to 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV). Given the context of using proceeds from a share issue to repay debt, CAP is the most appropriate classification.
2019-06-19 Polish
190617_RB_ujawnienie_PHR
Major Shareholding Notification Classification · 98% confidence The document is a formal notification submitted to the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego) based on Article 69 of the Polish Public Offering Act. The content details changes in shareholding percentages (specifically mentioning a registration of a capital increase via Series E shares) and the resulting number of shares and voting rights held by an individual (Robert Bożyk). This structure—reporting changes in significant share ownership thresholds—directly corresponds to the definition of a Major Shareholding Notification. In the provided schema, this aligns best with 'Major Shareholding Notification' (MRQ).
2019-06-17 Polish
Ujawnienie stanu posiadania - Content (PL)
Director's Dealing Classification · 95% confidence The document text is very short (441 characters) and explicitly states that the Management Board of Pharmena S.A. received a notification from Mr. Robert Bożyk on June 17, 2019, pursuant to Article 69 of the Act on Public Offering. It concludes by stating that this notification is attached as an appendix to the current report. This structure—a brief announcement referencing an attached document (likely an insider transaction report under Polish regulations, similar to DIRS)—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), as it is announcing the release of another document rather than being the full report itself. Given the specific nature of reporting insider transactions (Director's Dealing), if the attached document were available, it would be DIRS. However, since this text is only the *announcement* of the attached document, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, unless RNS is a better fit for general regulatory announcements not covered elsewhere. Since the content relates to a specific transaction notification (insider dealing), and it's a short announcement about a filing, RNS is often used for general regulatory disclosures in this context, but RPA specifically covers announcements about the publication of reports. Given the context of Polish regulatory filings, this is a mandatory disclosure. I will classify it as RNS as it is a general regulatory disclosure announcement that doesn't fit the specific DIRS definition (which usually implies the full transaction details, not just the announcement of receiving the notification). However, upon re-evaluation against the definitions, this is a mandatory regulatory disclosure regarding a change in shareholding/insider activity. Since DIRS is for the report of the transaction itself, and this is an announcement of receiving that report, RNS (General Regulatory Filings) is the safest fallback for a short regulatory notice that isn't a specific financial report (like ER or IR).
2019-06-17 Polish
190614 zawiadomienie KP
Major Shareholding Notification Classification · 98% confidence The document is a formal notification submitted to the Polish Financial Supervision Authority (Komisja Nadzoru Finansowego) based on Article 69 of the Polish Public Offering Act. It details a change in the percentage of shares held by an individual (Konrad Palka) following a capital increase. This type of filing specifically reports changes in significant share ownership thresholds by an individual or entity. This directly corresponds to the definition of 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds.
2019-06-14 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.